🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
1.730
+0.010 (0.58%)
At close: Nov 18, 2026, 4:00 PM EST
1.725
-0.005 (-0.29%)
After-hours: Nov 18, 2026, 5:22 PM EST

Grace Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
367231322154
Market Cap Growth
-15.76%129.06%-2.84%56.90%-62.03%-55.00%
Enterprise Value
1553207-108
Last Close Price
1.734.632.283.422.767.32

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PB Ratio
0.661.120.470.520.300.50
P/TBV Ratio
1.844.901.812.581.102.12

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
----0.010.00
Net Debt / Equity Ratio
-0.38-0.27-0.33-0.37-0.40-0.40
Net Debt / EBITDA Ratio
2.111.531.332.041.523.87
Net Debt / FCF Ratio
2.391.911.491.861.722.52
Quick Ratio
13.227.9211.5314.098.4113.56
Current Ratio
13.618.1011.7714.268.5913.89
Return on Equity (ROE)
-36.20%-11.94%-14.91%-19.82%-48.15%-11.98%
Return on Assets (ROA)
-10.19%-9.99%-14.35%-9.25%-10.96%-7.94%
Return on Capital Employed (ROCE)
-18.10%-17.20%-23.80%-15.70%-24.00%-9.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-69.15%-10.88%-30.59%-39.92%-206.80%-18.17%
FCF Yield
-24.54%-12.38%-47.65%-38.38%-77.64%-31.90%
Buyback Yield / Dilution
-25.20%-36.59%-26.85%-28.16%-21.09%-148.46%
SEC Filings: 10-K · 10-Q